With the current equity bull market now in its 10th year, the number of opportunities out there for deep value investors is extremely limited.
Indeed, a quick screen of the market for companies trading for less than net current asset value returns just 55 results, of which 20% are struggling biotechs, and nearly a third are Chinese firms listed in the US.
[feed url="https://hedgefundalpha.com/category/premium-featured-stories/feed/" number="5"]
But this isn't representative of the rest of the world. There are two regions in particular where deep value still prevails: South Korea and Japan.
If you’re looking for value stocks, and exclusive access to value-focused hedge fund managers, check out ValueWalk’s exclusive value newsletter, Hidden Value Stocks.
Both of...
Login required to continue reading.
Setup a free account to get access to this article (no credit card required).
View Full Article
